UNSPSC 51131822: Coagulation factor xiv or protein c

This classification denotes an antifibrinolytic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier JGH8MYC891. European Medicines Agency schedules Coagulation factor xiv in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12567MIG.

UNSPSC 51131822 Coagulation factor xiv or protein c is a Commodity code that nominally names a pharmaceutical product, yet the recent state and local procurement activity under this code shows a significant mismatch with that scope. Sourcewell, a State of Minnesota local government unit and service cooperative, posted RFP #061626 on May 12, 2026, seeking proposals for law enforcement equipment — a category bearing no relation to pharmaceutical coagulation factors or protein therapeutics. The solicitation, due June 16, 2026, establishes a contracting solution intended to serve thousands of governmental agencies, higher education institutions, K-12 school districts, nonprofit organizations, tribal governments, and other public entities across the United States and Canada. This disconnect between the UNSPSC code's stated scope and the actual procurement work suggests either a classification error in the state or local agency's tagging process or that this code carries materially different meaning in certain procurement jurisdictions than in the national standard taxonomy.

The geographic spread is nationwide and cross-border, with Sourcewell coordinating on behalf of multiple Washington counties (Franklin, Grant, Grays Harbor, Chelan, and Yakima) as well as participating entities throughout the United States and Canada. No other recent state or local opportunities appear in the record under this code. Given the profound scope mismatch between the Commodity code name and the law enforcement equipment solicitation, firms specializing in pharmaceutical products or services should not pursue activity under UNSPSC 51131822 without first confirming with individual issuing bodies that their specific procurement aligns with coagulation factors or protein-c products rather than law enforcement goods.